Metastasis, a critical phase of tumor progression, remains a primary challenge in treating
cancer and a major cause of cancer mortality. Cell-cell communication via extracellular …

Purpose To provide evidence-based recommendations to oncologists and others for the
treatment of patients with metastatic pancreatic cancer. Methods American Society of …

Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …

Purpose To provide evidence-based recommendations to oncologists and others on
potentially curative therapy for patients with localized pancreatic cancer. Methods ASCO …

Purpose To provide evidence-based recommendations to oncologists and others for
treatment of patients with locally advanced, unresectable pancreatic cancer. Methods …

Heparin has been recognized as a valuable anticoagulant and antithrombotic for several
decades and is still widely used in clinical practice for a variety of indications. The …

Thromboembolism is considered to have a substantial impact on outcomes in patients with
cancer. Although progress in cancer therapy and the advent of new anticancer agents such …

Venous thrombosis is a leading cause of morbidity and mortality in industrialized countries,
especially in the elderly. Many risk factors have been identified for venous thrombosis that …

Purpose Advanced pancreatic cancer (APC), in addition to its high mortality, accounts for the
highest rates of venous thromboembolic events (VTEs). Enoxaparin, a low–molecular weight …

Venous thromboembolism (VTE) is a common complication in patients with malignant
disease. Emerging data have enhanced our understanding of cancer-associated …